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Bone Marrow Wars: Attack of the Clones
Haroon Rehman MD1, Asha Chepkorir Sigei MD2, Kanishka Chakraborty MD1, Devapiran Jaishankar MD1
1Division of Medical Oncology, Dept of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN
2Department of Pathology, Quillen College of Medicine, East Tennessee State University, Johnson City, TN

INTRODUCTION
Multiple myeloma is characterized by the
malignant proliferation of clonal plasma
cells producing monoclonal paraproteins,
leading to multi-organ damage. On the
other hand monoclonal B-cell
lymphocytosis (MBCL) is characterized by
the malignant proliferation of clonal Blymphocytes, with potential to develop into
chronic lymphocytic leukemia (CLL) or small
lymphocytic lymphoma (SLL). CLL/SLL can
result in visceromegaly, anemia,
thrombocytopenia, fevers, night sweats
and unintentional weight loss. Literature
review demonstrates these two malignant
clonal bone marrow disorders are most
frequently seen independently in
patients(1); however, we report one rare
diagnostic challenge where both clonal
disorders were identified in a single patient
concurrently.
CASE DESCRIPTION
A 64-year-old man initially presented with
worsening back pain. Thoracic spine x-ray
revealed a T11 compression fracture,
confirmed by magnetic resonance
imaging.

CASE DESCRIPTION (continued)
Complete blood count revealed a white blood cell count of 7.3 K/uL with 54% lymphocyte
predominance and peripheral smear demonstrated a population of small lymphocytes with
round nuclei and an atypical chromatin pattern suggestive of CLL/MBCL. Flow cytometry
revealed a monoclonal B-cell CD5 positive, CD23 positive, CD10 negative population with an
absolute count of 1.6 K/uL. Due to the instability and pain associated with the spinal
fracture, patient had kyphoplasty performed and intraoperative bone biopsies were taken
from both T11 and T12 vertebrae. Interestingly each bone biopsy revealed involvement by
both a kappa-light chain restricted plasma cell neoplasm, ranging from 15% to 30%
cellularity, as well as a CD5-positive B-cell lymphocyte population. It suggested two
concurrent but pathologically distinct pathologies including plasma cell myeloma and a
separate B-cell lymphoproliferative disorder with immunophenotypic features suggestive of
CLL/MBCL. Bone marrow biopsy was performed for definitive evaluation and confirmed
multiple myeloma with 15-20% kappa-restricted plasma cells identified, and also confirmed
concurrent MBCL with CD5 and CD23-positive, kappa-restricted B-cells identified on bone
marrow flow cytometry. Adding an additional layer of complexity, bone marrow molecular
genetics revealed presence of a MYD88 mutation, raising concern for possible
lymphoplasmacytic lymphoma (LPL). However, secondary pathologic review ruled out LPL,
as the immunophenotypic pattern of the clonal B-cells was not consistent with that of LPL,
and although the MYD88 mutation is predominantly seen in LPL, it has also been seen in a
small percentage of CLL/SLL cases and exceedingly rarely described in MM as well. Serum
protein electrophoresis with immunofixation, serum quantitative immunoglobulins and
serum quantitative free light chain assay revealed findings consistent with IgG kappa
multiple myeloma and systemic CT imaging was negative for any lymphadenopathy,
confirming MBCL. Patient was started on first-line multiple myeloma systemic therapy for
transplant eligible patients and has demonstrated an excellent response to treatment thus
far.
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DISCUSSION
This patient case serves to demonstrate
the importance of maintaining a broad
differential when approaching
hematological problems; It also
underlines the necessity for a complete
diagnostic evaluation to identify rare
clinical conundrums such as with our
patient, allowing for proper and timely
treatment. While we use “Occam’s razor”
to explain multiple problems with a single
unifying diagnosis, the rare possibility of
divergent diagnosis is to always be
entertained.
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